Seppic has published new studies to further support the performance of Sepilift DPHP, a dipalmitoyl hydroxy proline lipovector. This anti-wrinkle ingredient moisturizes the skin and reduced the appearance of the visible signs of aging.
The new anti-aging, in vivo study was performed on 20 volunteers to evaluate the efficacy of the product versus a well-known benchmark lipopeptide. In comparison, the Sepilift DPHP had produced significant results while the lipopeptide at 3% did not show statistical anti-aging effects.
At a 1% use level, Sepilift DPHP has induced a statistically strong reduction of wrinkles compared to the placebo (-32%) and to the benchmark lipopeptide (-16%).
More info: www.seppic.com.